*Seminar 11

Update of Gastroesphageal Reflux Disease
Richard Rothstein, MD                                                                                          

In this session, the attendees will gain better understanding of the problem of GERD. This common condition has many contributing factors to it’s incidence and a variety of treatment options. Without treatment, it has significant impact on quality of life as well as having long term health implications.

*Seminar 12

Prostate Health Screenin/Prostate Health
Ronald Yap

The issues and recommendations related to this topic continue to evolve. During this session, we will discuss two common issues affecting the aging male: prostate enlargement (BPH) and prostate cancer screening.  We will review current guidelines. Up to date research, management options, and controversies will be reviewed.

*Seminar 13

Getting With The Beat: Managing Supraventricular Arrhythmia
Adam Chodosh, MD

Supraventricular arrhythmia such as accessory pathways, AV Nodal reentry, atrial flutter and atrial fibrillation can occur in patients of all ages. More options for both acute and long term management are available today. This session will review treatments including old and new medications and interventional procedures such as ablation for management and cure of these arrhythmias.

*Seminar 14

Update on Pediatric Dermatology
Stephen DelGiudice, MD

This session will provide the attendee with an update of common, and less common skin disorders in children. Images displayed will allow for easier identification of the particular abnormalities in clinical practice and there will be discussion of both etiology and treatment.

*Seminar 15

Contraceptive Pearls
Nancy Dirubbo, FNP-C, CTH

Choosing a contraceptive method is a complex decision. Most females will use several different methods over her reproductive lifetime. Clinicians need to be knowledgeable about all methods available including risks, benefits, contraindications, side effects and management for optimum use and effectiveness.

* Eligible for pharmacology contact hours